Molecular Cytogenetics Market, By Product Type (Instruments, Consumables, Software and Services), By Technology (FISH, aCGH), By Application (Genetic Disorder, Cancer, Personalized Medicine, Others.), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Apr 2023

Code : CMI2491

Pages :145

Formats :

Excel and PDF

Industry : Biotechnology

Leading Companies

Global Molecular Cytogenetics Market- Regional Analysis

Global Molecular Cytogenetics Market: Key Developments

In September 2022, the Azerbaijan Thalassemia Center, medical institution and BGI, leading integrated solutions provider of precision medicine, held a virtual signing ceremony to seal a collaboration agreement. The partnership aims to improve thalassemia screening in Azerbaijan through genetic technology.

In July 2020, two top cytogeneticists from leading institutions in Netherlands and France reported that Bionano Genomics' Saphyr demonstrates 100% concordance to standard cytogenetics in genetic disorders.

Global Molecular Cytogenetics Market - Key Players

Major players operating in the global molecular cytogenetics market include Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems.

Companies covered:

Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems.